ProfileGDS4718 / 203525_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 89% 87% 87% 90% 79% 79% 89% 89% 90% 90% 89% 86% 80% 85% 87% 90% 78% 81% 57% 89% 88% 91% 89% 89% 83% 91% 78% 88% 79% 86% 83% 89% 90% 88% 85% 88% 88% 88% 89% 87% 78% 78% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.8150687
GSM549102patient 115, normal, homogenized [OPG study]8.9229889
GSM549104patient 119, normal, homogenized [OPG study]8.8273187
GSM549108patient 138, normal, homogenized [OPG study]8.5768187
GSM549119patient 077, normal, homogenized [OPG study]9.2473290
GSM549133patient 032, cancer, homogenized [OPG study]7.8850379
GSM549139patient 042, cancer, homogenized [OPG study]7.7448379
GSM549099patient 107, normal, homogenized [OPG study]8.9823789
GSM549109patient 139, normal, homogenized [OPG study]8.9554189
GSM549110patient 046, normal, homogenized [OPG study]9.2882690
GSM549114patient 063, normal, homogenized [OPG study]9.4449290
GSM549122patient 082, normal, homogenized [OPG study]8.9926389
GSM549134patient 033, cancer, homogenized [OPG study]8.6263286
GSM549136patient 036, cancer, homogenized [OPG study]7.9481780
GSM549140patient 044, cancer, homogenized [OPG study]8.5355585
GSM549111patient 047, normal, homogenized [OPG study]8.7944587
GSM549113patient 057, normal, homogenized [OPG study]9.4019590
GSM549132patient 031, cancer, homogenized [OPG study]7.6758578
GSM549137patient 038, cancer, homogenized [OPG study]7.9828481
GSM549142patient 047, cancer, homogenized [OPG study]6.0326157
GSM549100patient 110, normal, homogenized [OPG study]8.9477789
GSM549107patient 135, normal, homogenized [OPG study]8.9046688
GSM549115patient 068, normal, homogenized [OPG study]9.5479991
GSM549116patient 072, normal, homogenized [OPG study]9.0591289
GSM549120patient 078, normal, homogenized [OPG study]9.0070189
GSM549131patient 030, cancer, homogenized [OPG study]8.3534783
GSM549118patient 074, normal, homogenized [OPG study]9.4402391
GSM549129patient 027, cancer, homogenized [OPG study]7.6622578
GSM549123patient 088, normal, homogenized [OPG study]8.9225188
GSM549124patient 006, cancer, homogenized [OPG study]7.6264479
GSM549126patient 015, cancer, homogenized [OPG study]8.5521286
GSM549128patient 025, cancer, homogenized [OPG study]8.279783
GSM549103patient 117, normal, homogenized [OPG study]8.8895289
GSM549117patient 073, normal, homogenized [OPG study]9.4352890
GSM549138patient 041, cancer, homogenized [OPG study]8.8791688
GSM549141patient 045, cancer, homogenized [OPG study]8.5622385
GSM549130patient 028, cancer, homogenized [OPG study]8.8411488
GSM549101patient 111, normal, homogenized [OPG study]8.8638388
GSM549105patient 128, normal, homogenized [OPG study]8.8358788
GSM549106patient 134, normal, homogenized [OPG study]9.115589
GSM549112patient 048, normal, homogenized [OPG study]8.8596987
GSM549125patient 011, cancer, homogenized [OPG study]7.6149478
GSM549127patient 024, cancer, homogenized [OPG study]7.6913578
GSM549135patient 035, cancer, homogenized [OPG study]7.524476